Hunger in America

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.

This toolkit, comprised of fact sheets, worksheets, sample communications materials, and sample social media is designed to help aid how you support your own mental health journey, along with your community’s.

Good Pill will provide direct access to hundreds of life-saving medications and save families $150+/month on healthcare cost

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.

The Outcomes of Implementing and Integrating Comprehensive Medication Management in Team-Based Care: A Review of the Evidence on Quality, Access and Costs, December 2023

Uninsured adults and those in worse health continue to report higher rates of not getting care due to costs

Around one fourth of the United States population does not have adequate health literacy.
Health literacy is defined as the ability to obtain, read, understand, and apply healthcare
information

There are multiple factors that will impact an individual patient’s choice on how to go about getting their prescription medication. It can be overwhelming to navigate this complex issue.

A Fireside Chat with AAM Chair, Christine Baeder and Mark Cuban, Entrepreneur and Cost Plus founder

Good Pill will provide direct access to hundreds of life-saving medications and save families $150+/month on healthcare cost

Three Healthcare Organizations Join Forces to Save Lives

Once the continuous enrollment ends, it is estimated between 5 -14 million individuals will be affected

The pharmacy industry sees at least five changes

Today’s release of new 2020 Census data provides population counts of nearly 1,500 race and ethnicity groups and American Indian and Alaska Native (AIAN) tribes and villages.

Recent federal legislative and regulatory updates in managed care pharmacy have prioritized topics ranging from expedited access to novel therapeutics to the health disparities and equity concerns affecting patient populations nationwide, but progress on these developments will depend on the impact of the midterm elections